​

MiNK Therapeutics Ownership | Who Owns MiNK Therapeutics?

OverviewForecastFinancialsChartTranscripts

MiNK Therapeutics Ownership Summary

MiNK Therapeutics is owned by 64.18% insiders, and 35.82% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.05% of its assets in MiNK Therapeutics shares.

INKT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMiNK Therapeutics-64.18%35.82%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20251-160---1---
Jun 30, 20251-144-99.14%-205.71%1---100.00%
Mar 31, 20251-95.65%16,667-97.94%-1.00%--100.00%1-83.33%
Dec 31, 202423-11.54%809,544-4.38%244.65%6-33.33%6-14.29%
Sep 30, 202426-13.33%846,639-5.78%231.83%9-7-30.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv49.29K1.05%-
Vanguard Institutional Extnd Mkt Idx Tr10.07K0.21%-
Fidelity Extended Market Index6.70K0.14%1.30K
Vanguard Instl Ttl Stck Mkt Idx Tr2.12K0.05%-
Fidelity Nasdaq Composite Index1.90K0.04%-
Fidelity Total Market Index1.88K0.04%-
Spartan Extended Market Index Pool E1.38K0.03%1.26K
Spartan Extended Market Index Pool F1.57K0.03%11.00
Fidelity Series Total Market Index1.39K0.03%-
iShares Micro-Cap ETF999.000.03%-

Recent Insider Transactions

DateNameRoleActivityValue
Mar 10, 2026Ryan Barbara-Sell$7.65K
Mar 10, 2026Ryan Barbara-Sell$4.58K
Mar 09, 2026Ryan Barbara-Sell$2.03K
Mar 10, 2026Ryan Barbara-Sell$7.78K
Mar 02, 2026Ryan Barbara-Sell$1.08K

Insider Transactions Trends

DateBuySell
2026 Q1-6
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--

INKT Ownership FAQ

Who Owns MiNK Therapeutics?

MiNK Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 64.18% insiders and 35.82% retail investors. The average institutional ownership in MiNK Therapeutics's industry, Biotech Stocks , is 381.47%, which MiNK Therapeutics falls below.

Does Blackrock own MiNK Therapeutics?

BlackRock is not among the top 10 institutional shareholders of MiNK Therapeutics.

Who is the top mutual fund holder of MiNK Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of MiNK Therapeutics shares, with 1.05% of its total shares outstanding invested in 49.29K MiNK Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools